Related Experiment Video
Updated: Aug 14, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment
Juan M Aranda1, Gregory W Woo, Richard S Schofield
1Division of Cardiovascular Medicine, College of Medicine, University of Florida Health Science Center, Gainesville, Florida, USA. arandjm@medicine.ufl.edu
Insights
Cardiac resynchronization therapy (CRT) improves heart failure outcomes for most patients. A new strategy helps manage non-responders by integrating device data with advanced heart failure treatments.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Cardiac resynchronization therapy (CRT) is a standard treatment for systolic heart failure (HF) with ventricular dyssynchrony.
- Most patients benefit from CRT, showing improved quality of life, functional class, exercise capacity, and ventricular function.
Purpose of the Study:
- To present a step-by-step management and troubleshooting strategy for initial CRT non-responders.
- To integrate device diagnostics with advanced HF therapies for optimized patient outcomes.
Main Methods:
- Development of a management algorithm for non-responder patients.
- Collaboration between heart failure and electrophysiology specialists.
Main Results:
- The proposed strategy aims to improve and sustain clinical outcomes in CRT recipients.
- Addresses the persistent issue of initial non-responder rates.
Conclusions:
- A comprehensive, collaborative approach is essential for managing CRT non-responders.
- Integrating device data and advanced HF therapies can enhance CRT effectiveness.
Abstract:
Cardiac resynchronization therapy (CRT) is an established adjunctive treatment for patients with systolic heart failure (HF) and ventricular dyssynchrony. The majority of recipients respond to CRT with improvements in quality of life, New York Heart Association functional class, 6-min walk test, and ventricular function. Management of HF after CRT may include up-titration of neurohormonal blockade and an exercise prescription through cardiac rehabilitation to further improve and sustain clinical outcomes. Diagnostic data provided by the CRT device may help to facilitate and optimize treatment. Initial nonresponder rates remain problematic. We suggest a simple step-by-step management and troubleshooting strategy that integrates device function with advanced HF therapy in patients who do not initially respond to CRT. This algorithm represents a new, comprehensive, collaborative approach between the HF and electrophysiology specialists to further improve and sustain outcomes in the field of CRT.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease III: Medical Management

